Short Interest in PureTech Health plc (NASDAQ:PRTC) Increases By 77.7%

PureTech Health plc (NASDAQ:PRTC) saw a significant growth in short interest in December. As of December 31st, there was short interest totalling 35,900 shares, a growth of 77.7% from the December 15th total of 20,200 shares. Based on an average daily volume of 4,500 shares, the short-interest ratio is presently 8.0 days.

PureTech Health Stock Performance

NASDAQ:PRTC traded up $0.10 during midday trading on Friday, hitting $18.19. 13,996 shares of the company traded hands, compared to its average volume of 4,260. PureTech Health has a 12-month low of $17.00 and a 12-month high of $34.00. The firm’s fifty day moving average is $20.60 and its 200-day moving average is $21.12.

About PureTech Health

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.